Myriad Genetics

Myriad Genetics is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: transitioning and expanding its hereditary cancer testing market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. At the end of fiscal year 2015, Myriad had annual revenue of approximately $723.1 million and 2,038 employees, Myriad is the global leader and pioneer in the molecular diagnostics field with twelve innovative diagnostic products. Through our proprietary technologies, we believe we are positioned to identify important disease genes, the proteins they produce, and the biological pathways in which they are involved to better understand the genetic basis of human disease and the role that genes and their related proteins may play in the disease process.

Company Growth (employees)
Type
Public
HQ
Salt Lake City, US
Founded
1992
Size (employees)
2,400 (est)+9%
Website
myriad.com
Myriad Genetics was founded in 1992 and is headquartered in Salt Lake City, US

Myriad Genetics Office Locations

Myriad Genetics has offices in Salt Lake City, Austin, Zürich and South San Francisco
Salt Lake City, US (HQ)
320 Wakara Way
South San Francisco, US
341 Oyster Point Blvd
Zürich, CH
95 Leutschenbachstrasse
Austin, US
3300 Duval Rd

Myriad Genetics Financials and Metrics

Myriad Genetics Financials

Myriad Genetics's revenue was reported to be $753.8 m in FY, 2016
USD

Revenue (Q3, 2017)

196.9 m

Net income (Q3, 2017)

4.2 m

EBIT (Q3, 2017)

12.9 m

Market capitalization (13-Nov-2017)

2.3 b

Cash (31-Mar-2017)

123.8 m

EV

2.3 b
Myriad Genetics's current market capitalization is $2.3 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

778.2 m723.1 m753.8 m

Revenue growth, %

(7%)4%

EBIT

274.4 m134.2 m166.8 m

EBIT margin, %

35%19%22%
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

202.5 m204.1 m182.9 m168.8 m184.4 m180 m183.5 m193.3 m190.5 m177.5 m196.5 m196.9 m

Operating expense total

119.6 m121.1 m127.6 m142.9 m148.1 m144.2 m140.2 m148.1 m147.9 m171.3 m183.3 m184 m

EBIT

82.9 m83 m55.3 m25.9 m36.3 m35.7 m43.3 m45.2 m42.6 m6.2 m13.2 m12.9 m

EBIT margin, %

41%41%30%15%20%20%24%23%22%3%7%7%
USDFY, 2014FY, 2015FY, 2016

Cash

64.8 m64.1 m68.5 m

Accounts Receivable

3.8 m1.9 m3.3 m

Inventories

23.9 m25.1 m38.3 m

Current Assets

322.4 m283.6 m314.5 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

85 m71.6 m85.8 m69.8 m59.7 m55.2 m87.4 m134.7 m120.5 m86.9 m108.1 m123.8 m

Accounts Receivable

1.8 m3.5 m3.2 m11.2 m5.3 m3 m1.6 m5.1 m2.9 m4.6 m3.9 m4.4 m

Inventories

18.9 m24.8 m20.2 m29.4 m34.3 m29.1 m25.3 m53.9 m51.3 m47.4 m

Current Assets

458.7 m454.5 m338.2 m335.4 m320.1 m282.4 m307.3 m375.5 m372.4 m322.9 m341.6 m348.3 m
USDFY, 2014FY, 2015FY, 2016

Net Income

176.2 m80.2 m125.3 m

Depreciation and Amortization

13.8 m25 m26.7 m

Accounts Receivable

(1.9 m)2.5 m(900 k)

Inventories

(16 m)(800 k)(15 m)
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

55.5 m50.4 m36.8 m16 m24 m21.5 m26.6 m30.3 m32.6 m(1.2 m)5.9 m4.2 m

Accounts Receivable

11.2 m5.3 m3 m1.6 m5.1 m2.9 m4.6 m3.9 m4.4 m

Inventories

24.8 m20.2 m29.4 m34.3 m29.1 m25.3 m53.9 m51.3 m47.4 m

Accounts Payable

25.7 m16.8 m18 m15.8 m16.5 m13.8 m19.9 m22.9 m26.8 m
USDY, 2017

EV/EBIT

180.6 x

Revenue/Employee

89.3 k

Financial Leverage

1.7 x
Show all financial metrics

Myriad Genetics Market Value History

Myriad Genetics's Web-traffic and Trends

Myriad Genetics Online and Social Media Presence

Myriad Genetics Company Life and Culture

You may also be interested in